Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
4,997 people get CVS articles and Market Currents by email alert.
Get email alerts on CVS »
FOCUS
|
PRO
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
Why We Like CVS CaremarkUlfberht Capital • Mon, Apr 8
-
Earnings Analysis: CVS CaremarkCapitalCube • Wed, Nov 7, 2012
-
Watch For Walgreen-Express Scripts Impact In CVS Caremark EarningsTrefis • Mon, Nov 5, 2012
To learn more about Seeking Alpha Pro, click here.
-
CVS Caremark's CEO Hosts 2012 Analyst Day (Transcript)Thu, Dec 13, 2012
-
CVS Caremark's CEO Discusses Q4 2011 Results - Earnings Call TranscriptWed, Feb 8, 2012 • 1 Comment
-
CVS Caremark Corporation - Analyst/Investor DayTue, Dec 20, 2011
-
CVS Caremark's CEO Discusses Q3 2011 Results - Earnings Call TranscriptThu, Nov 3, 2011 • 1 Comment
-
CVS Caremark Corporation Q2 2010 Earnings Call TranscriptThu, Jul 29, 2010
-
CVS Caremark Q1 2010 Earnings Call TranscriptTue, May 4, 2010
-
CVS Caremark Corporation Q4 2009 Earnings Call TranscriptMon, Feb 8, 2010
-
CVS Caremark Q3 2009 Earnings Call TranscriptThu, Nov 5, 2009
-
CVS Caremark Q2 2009 Earnings Call TranscriptTue, Aug 4, 2009
-
PR Newswire (Tue, 8:30AM)
-
at Fox Business (Jun 7, 2013)
-
PR Newswire (Jun 3, 2013)
-
at CNBC.com (May 30, 2013)
-
PR Newswire (May 23, 2013)
-
PR Newswire (May 14, 2013)
-
PR Newswire (May 14, 2013)
-
PR Newswire (May 13, 2013)
-
at Fox Business (May 13, 2013)
-
PR Newswire (May 9, 2013)
-
at MarketWatch.com (May 1, 2013)
-
at CNBC.com (May 1, 2013)
-
at CNBC.com (May 1, 2013)
-
at CNBC.com (May 1, 2013)
-
at Fox Business (May 1, 2013)
-
at CNBC.com (May 1, 2013)
-
PR Newswire (May 1, 2013)
-
at CNBC.com (Apr 30, 2013)
-
PR Newswire (Apr 30, 2013)
-
at MarketWatch.com (Apr 28, 2013)
CVS vs. ETF Alternatives
Company Description
CVS Caremark Corporation (“CVS Caremark”, the “Company”, “we” or “us”) is the largest pharmacy health care provider in the United States. As a fully integrated pharmacy services company, we believe we can drive value for our customers by effectively managing pharmaceutical costs and improving... More
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Monday, June 14, 2010, 3:11 PM CVS Caremark (CVS -0.3%) launches a new $2B share buyback program, saying it expects to generate "significantly more free cash flow" over the next five years. The announcement follows a very public spat with Walgreen (WAG). Comment!
- Monday, June 14, 2010, 11:14 AM Consensus Advisors' survey of the top five healthiest retailers: Amazon.com (AMZN), Aeropostale (ARO), Urban Outfitters (URBN), CVS Caremark (CVS) and Wal-Mart (WMT). The firm looked at criteria such as growth, debt levels and ability to control pricing. Comment!
- Wednesday, June 9, 2010, 10:24 AM CVS Caremark (CVS -1.8%) retaliates against Walgreens' (WAG -2.1%) withdrawal from its drug benefits network, announcing that it "has no choice" but to terminate Walgreens' participation in its retail pharmacy network in 30 days. (PR) Comment!
- Monday, June 7, 2010, 2:24 PM CVS Caremark (CVS -7.5%) says Walgreens' (WAG -1.6%) unexpected decision to exit CVS pharmacy network plans is "nothing more than a transparent effort to raise its reimbursement rates." Express Scripts (ESRX +5.3%) and Medco (MHS +4.1%) shares gain as companies seen benefiting from the Walgreens announcement. (PR) Comment!
- Monday, June 7, 2010, 9:23 AM CVS Caremark (CVS) shares stumble after Walgreens (WAG) says it will not participate as a provider in any new and renewed prescription drug plans awarded after June 7 to CVS Caremark's pharmacy benefit manager. Walgreens cites CVS Caremark's "management practices toward Walgreens." CVS -7.6%, WAG -2.4% premarket. (PR) Comment!
-
Monday, June 7, 2010, 9:00 AM
Premarket gainers: KRY +52%. TLCR +46%. IRE +8%. BPAX +8%. CTIC +7%. BMY +7%. EGLE +4%. VVUS +4%. S +4%.
Losers: DCTH -10%. OTE -7%. CVS -4%. Comment! - Wednesday, May 12, 2010, 9:03 AM CVS (CVS +0.25%) CEO Thomas Ryan says he'll retire in May 2011. Current COO Larry Merlo will likely be his replacement. Comment!
- Tuesday, May 4, 2010, 7:12 AM CVS Caremark (CVS): Q1 EPS of $0.60 beats by $0.02. Revenue of $23.8B (+1.6%) vs. $24.1B. (PR) Comment!
- Tuesday, May 4, 2010, 12:05 AM Notable earnings before Tuesday's open: ADM, AMT, ARM, BHI, BYD, COCO, CTSH, CVS, DPZ, DUK, EMR, FE, HNT, MA, MAC, MMC, MRK, MRO, NI, NYX, PFE, RDC, RDN, SE, SIRI, SNH, SRE, SU, TAP, TEVA, THC, VNO Comment!
- Monday, March 8, 2010, 10:16 AM Goldman Sachs' (GS) list of the 10 most-loved hedge fund stocks: Apple (AAPL), Pfizer (PFE), Bank of America (BAC), Google (GOOG), JPMorgan Chase (JPM), Microsoft (MSFT), Mastercard (MA), Directv (DTV), Wells Fargo (WFC), CVS Caremark (CVS). 5 Comments
- Friday, February 19, 2010, 2:23 PM Top prescription provider CVS Caremark (CVS) plans a "substantial" investment into integration of the five disparate parts of its pharmacy-benefits management unit. Information systems at various acquisitions are currently just "cobbled together." 2 Comments
-
Monday, February 8, 2010, 9:00 AM
Premarket gainers: CAGC +13%. HAS +8%. CIT +5%. CVS +4%. MOT +4%.
Losers: NBG -9%. AIB -7%. LYG -6%. PC -5%. ING -4%. BCS -4%. Comment! - Monday, February 8, 2010, 7:41 AM CVS Caremark (CVS): Q4 EPS of $0.79 beats by $0.01. Revenue of $25.8B (+7%) vs. $26.2B. Shares +1.3% premarket. (PR) Comment!
- Monday, February 8, 2010, 12:05 AM Notable earnings before Mondays open: CVS, GOLD, HAS, HMY, L, LO, NDAQ, NVE Comment!
- Saturday, February 6, 2010, 2:40 PM As major drug patents begin to expire, the big winners could be CVS Caremark (CVS) and Walgreen (WAG). Their profits could rise at least 20% starting next year as generics eat away at over $100B in sales for branded drugs. 6 Comments
- Friday, February 5, 2010, 10:51 AM As patent protection expires on the world's best-selling drugs - Pfizer's (PFE) cholesterol drug Lipitor and blood thinner Plavix - profit gains of 20% could be in the offing in 2011 for big pharmacy chains like CVS Caremark (CVS) and Walgreen (WAG). Generics can be twice as profitable as branded drugs for pharmacies. Comment!
LATEST REPLIES


